Give the gift of LIFE! Support the Population Research Institute!

[pri_banner_wppb]

Topics: Barr Laboratories

FDA Prepares Sell-Out on MAP



11 Aug 2006     Vol. 8 / No. 31 FDA Prepares Sell-Out on MAP After resisting for years feminists determined to make high-dosage steroids available to women and girls without a prescription, it seems that the Bush Administration is about to cave in to political pressure and make the morning-after pill (MAP) accessible over the counter to those over 18.  Not only will this result in the deaths of more unborn children since MAP often acts after …

Read more.




New Report on FDA Approval of ‘Emergency Contraception’



Press Release Source: Population Reseach New Report on FDA Approval of ‘Emergency Contraception’ WASHINGTON, DC, 31 March 2004 — Population Research Institute has released an in-depth report on so-called “emergency contraception.” The U.S. Food and Drug Administration (FDA) has delayed its decision to act on Women’s Capital Corporation/Barr Laboratories application for over-the-counter (OTC) status for so-called “emergency contraception”(EC), the morning-after pill (MAP). Opposition to OTC/MAP involves concerns that OTC/MAP would increase rates of rape, STDs, …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.